Africa is facing a concerning surge in mpox cases, particularly the more transmissible and deadly Clade 1b strain. The WHO has declared an international health emergency, highlighting the need for a coordinated global response. The outbreak has raised concerns about the lack of investment in research and development for mpox, despite the growing threat.
The war in Gaza has created a critical situation where polio is on the rise. With vaccination rates plummeting and sanitation conditions deteriorating, aid groups are calling for an immediate ceasefire to allow for a mass vaccination campaign to prevent an outbreak. The World Health Organization and UNICEF are urging a seven-day pause to administer 1.6 million doses of polio vaccine, aiming to reach over 600,000 children. However, the logistical challenges, including destroyed infrastructure, lack of transportation, and security concerns, pose significant obstacles to this urgent endeavor.
Monkeypox, or mpox, a cousin of smallpox, has been declared a global health emergency by the World Health Organization (WHO) for the second time in two years. This resurgence is driven by a new, more virulent strain, raising concerns about its spread, particularly in India. This article explores the transmission, symptoms, prevention, and treatment of mpox, highlighting the importance of international cooperation and India’s preparedness for a potential outbreak.
A nationwide doctors’ strike, organized by the Indian Medical Association (IMA), began on Saturday, August 17th, in response to the brutal murder and rape of a doctor in Kolkata. The strike, impacting most hospitals across the country, has disrupted routine services, including outpatient departments (OPDs) and elective surgeries. While emergency services remain operational, the strike highlights the growing concern and anger within the medical community.
The Indian Medical Association (IMA) has called for a 24-hour nationwide strike today, August 17, to protest the alleged rape and murder of a trainee doctor in Kolkata. Medical professionals across the country are participating in the strike, withdrawing non-emergency services and holding protests to demand justice and improved safety for healthcare workers.
Gaza has reported its first polio case in 25 years, raising concerns about a potential outbreak in the besieged territory amidst the ongoing war with Israel. The case was confirmed in a 10-month-old child who was unvaccinated, highlighting the urgent need for a ceasefire to allow for crucial vaccination efforts.
A recent storyline in Emily in Paris highlighted the possibility of false positive pregnancy tests. While rare, these can occur due to various factors including medication, recent miscarriages, fertility treatments, and even peri-menopause. This article explores the common causes of false positives, offering expert advice on when to take a test and what to do if you get a questionable result.
German authorities have issued a warning against gummy bears containing muscimol, a hallucinogenic toxin found in fly agaric mushrooms. These gummies, marketed by the company Deutsche Cannabis Manufaktur (DCM), are available online and are labeled as being for experienced users only. The Federal Office for Consumer Protection and Food Safety cautions that these gummies are harmful to health, especially for children, due to their potential for confusion with regular candy.
Scientists have uncovered a key factor behind multisystem inflammatory syndrome in children (MIS-C), a rare but serious complication following COVID-19 infection. The immune system, in a case of mistaken identity, targets a protein called SNX8, mistaking it for a part of the SARS-CoV-2 virus. This discovery could lead to improved diagnosis and understanding of the condition.
Cingulate Inc.’s (CING) shares skyrocketed after the company secured a European patent for its groundbreaking ADHD treatment, CTx-1301. This patent covers a significant portion of Europe, including the UK, solidifying Cingulate’s position in the global ADHD market. The company is also preparing to submit a New Drug Application (NDA) to the FDA, marking a crucial step towards bringing this innovative treatment to US patients.
